SHOLEKHAH, Mutiah (2018) EVALUASI RASIONALITAS OBAT ANTIDIABETIK PADA PASIEN DIABETES MELITUS TIPE II DI INSTALASI RAWAT INAP RSUD SURAKARTA TAHUN 2017. Skripsi thesis, Universitas Setia Budi Surakarta.
![[img]](http://repo.setiabudi.ac.id/style/images/fileicons/text.png) |
Text
INTISARI.pdf Download (89kB) |
|
Text
SKRIPSI.pdf Download (4MB) |
Abstract
Diabetes Mellitus (DM) is a metabolic disease group with hyperglycemia characteristic occurring due to insulin secretion disorder, insulin working disorder, or both of them. Not optimal treatment efforts in patients with type II diabetes in Indonesia and the prevalence of type II diabetes mellitus in Indonesia is increasing so that researchers interested to see the description of the use of antidiabetic drugs and evaluate the rationality of the use of antidiabetic drugs in patients with type II DM in RSUD Surakarta Hospital Installation in 2017. This study was a non-experimental research. Data was collected restrospectively and analyzed descriptively. Sampling technique employed was purposive sampling. Data qualifying inclusive and exclusive criteria consisted of 42 patients. The research was conducted by evaluating the rationality of antidiabetic drug based on appropriate patient, appropriate indication, appropriate drug, and appropriate dosage indicators. The data obtained was compared with Clinical Pathways and PERKENI (2015). From 42 patients result of research showed that antidiabetic drug used in type-II DM patient in inpatient unit of Surakarta Local General Hospital in 2017 was 100% insulin consisting of Novorapid 11.9%, Lavemir 2.4%, combined Novorapid and Lavemir 71.4%, combined Novorapid and Lantus 11.9%, and combined Novorapid, Lavemir, and Lantus 2.4%. Evaluation on antidiabetic drug rationality in type-II DM based on Clinical Pathway was 100% and according to PERKENI (2015) included appropriate patient 92,9%, appropriate indication 100%, appropriate drug 95,2%, and appropriate dosage 92,9%. Keywords: rationality evaluation, antidiabetic drug, type-II DM
| Item Type: | Thesis (Skripsi) |
|---|---|
| Uncontrolled Keywords: | rationality evaluation, antidiabetic drug, type-II DM |
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Fakultas Farmasi > Prodi S1 Farmasi |
| Depositing User: | Tifany Nur Arfiana |
| Date Deposited: | 23 Feb 2019 04:21 |
| Last Modified: | 23 Feb 2019 04:21 |
| URI: | http://repo.setiabudi.ac.id/id/eprint/864 |
Actions (login required)
 |
View Item |
